
Meridian Bioscience VIVO
Quartalsbericht 2022-Q4
hinzugefügt 09.02.2023
Meridian Bioscience Operativer Cashflow 2011-2026 | VIVO
Operativer Cashflow Jährlich Meridian Bioscience
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 82.4 M | 66.9 M | 48 M | 36.2 M | 34.8 M | 41.4 M | 37.2 M | - | - | 44.4 M | 42.4 M | 22.5 M |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 82.4 M | 22.5 M | 45.6 M |
Operativer Cashflow Vierteljährlich Meridian Bioscience
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -2.35 M | - | - | - | 35.6 M | - | 41.5 M | - | 25.1 M | 31.7 M | 15.7 M | 25.1 M | 5.29 M | 28.5 M | 21.1 M | 5.29 M | 9.49 M | 23.6 M | 13.8 M | 9.41 M | 5.17 M | 32.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 9.34 M | - | - | - | 16 M | 31.9 M | 18.9 M | 16 M | 12.5 M | 16.6 M | 10.3 M | 12.5 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 41.5 M | -2.35 M | 18.1 M |
Operativer Cashflow anderer Aktien in der Diagnostik & Forschung
| Name | Operativer Cashflow | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Agilent Technologies
A
|
1.48 B | $ 110.24 | -2.86 % | $ 33.5 B | ||
|
Centogene N.V.
CNTG
|
-21.7 M | - | -6.23 % | $ 30.6 M | ||
|
Waters Corporation
WAT
|
653 M | $ 289.16 | -3.79 % | $ 17.2 B | ||
|
Exagen
XGN
|
-13.6 M | $ 2.68 | -3.94 % | $ 57.8 M | ||
|
Enzo Biochem
ENZ
|
-26.3 M | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
491 M | - | - | $ 19.8 B | ||
|
Akumin
AKU
|
65.4 M | - | -17.87 % | $ 25.9 M | ||
|
Burning Rock Biotech Limited
BNR
|
-478 M | $ 16.36 | -11.57 % | $ 176 M | ||
|
Sotera Health Company
SHC
|
287 M | $ 13.13 | -3.03 % | $ 3.73 B | ||
|
Check-Cap Ltd.
CHEK
|
-8 M | - | - | $ 9.42 M | ||
|
Heska Corporation
HSKA
|
-21.8 M | - | - | $ 1.31 B | ||
|
BioNano Genomics
BNGO
|
-16.3 M | $ 1.16 | 0.87 % | $ 6.32 M | ||
|
DermTech
DMTK
|
-77 M | - | -11.32 % | $ 2.94 M | ||
|
Aspira Women's Health
AWH
|
-32.2 M | - | -6.19 % | $ 10.5 M | ||
|
DexCom
DXCM
|
1.44 B | $ 62.25 | -5.81 % | $ 24.3 B | ||
|
Accelerate Diagnostics
AXDX
|
-48.7 M | - | -61.36 % | $ 2.46 M | ||
|
Global Cord Blood Corporation
CO
|
614 M | - | - | $ 399 M | ||
|
Genetic Technologies Limited
GENE
|
-5.66 M | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-524 M | - | 0.12 % | $ 80.1 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-18.4 M | - | -20.0 % | $ 1.06 M | ||
|
Castle Biosciences
CSTL
|
64.9 M | $ 23.53 | -4.74 % | $ 654 M | ||
|
Charles River Laboratories International
CRL
|
738 M | $ 159.16 | -3.62 % | $ 7.89 B | ||
|
Quest Diagnostics Incorporated
DGX
|
1.89 B | $ 195.51 | -1.33 % | $ 21.7 B | ||
|
Organovo Holdings
ONVO
|
-9.46 M | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
-4.87 M | - | -16.95 % | $ 1.54 M | ||
|
Biocept
BIOC
|
-13.3 M | - | -13.05 % | $ 7.29 M | ||
|
PerkinElmer
PKI
|
583 M | - | -0.91 % | $ 14.7 B | ||
|
Invitae Corporation
NVTA
|
-493 M | - | - | $ 21.2 M | ||
|
Interpace Biosciences
IDXG
|
4.65 M | $ 1.68 | -2.89 % | $ 7.37 M | ||
|
Motus GI Holdings
MOTS
|
-11.2 M | - | -34.28 % | $ 263 K | ||
|
QIAGEN N.V.
QGEN
|
674 M | - | - | $ 10.6 B | ||
|
Neogen Corporation
NEOG
|
58.2 M | $ 8.7 | -4.92 % | $ 1.89 B | ||
|
Chembio Diagnostics
CEMI
|
-12.7 M | - | 0.22 % | $ 16.8 M | ||
|
Laboratory Corporation of America Holdings
LH
|
1.64 B | $ 264.2 | -1.56 % | $ 22 B | ||
|
Psychemedics Corporation
PMD
|
-1.48 M | - | -1.84 % | $ 15.3 M | ||
|
Precipio
PRPO
|
-3.56 M | $ 25.97 | -4.52 % | $ 33.7 M | ||
|
CareDx, Inc
CDNA
|
42 M | $ 16.78 | -3.95 % | $ 894 M | ||
|
Quotient Limited
QTNT
|
-77.6 M | - | -11.32 % | $ 1.1 M | ||
|
Syneos Health
SYNH
|
450 M | - | - | $ 4.46 B | ||
|
Renalytix AI plc
RNLX
|
-30.1 M | - | 5.66 % | $ 22.7 M | ||
|
VolitionRx Limited
VNRX
|
-25.9 M | $ 0.2 | 1.87 % | $ 19.2 M | ||
|
Bioventus
BVS
|
74.7 M | $ 8.94 | -3.46 % | $ 596 M | ||
|
Co-Diagnostics
CODX
|
-22.1 M | $ 4.4 | 101.83 % | $ 129 M | ||
|
Danaher Corporation
DHR
|
6.42 B | $ 181.52 | -3.27 % | $ 129 B | ||
|
Surmodics
SRDX
|
248 K | - | - | $ 608 M | ||
|
ENDRA Life Sciences
NDRA
|
-7.4 M | $ 4.29 | -6.54 % | $ 2.3 M |